Fidelity Select Pharmaceuticals Portfolio (FPHAX)
36.81
+0.54
(+1.49%)
USD |
Aug 25 2026
FPHAX Asset Allocations & Exposures
Asset Allocation
As of June 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.23% |
| Stock | 98.54% |
| Bond | 0.33% |
| Convertible | 0.00% |
| Preferred | 0.46% |
| Other | 0.44% |
Market Capitalization
As of June 30, 2026
| Large | 72.20% |
| Mid | 7.46% |
| Small | 20.33% |
Region Exposure
| Americas | 69.97% |
|---|---|
|
North America
|
69.62% |
| Canada | 1.02% |
| United States | 68.60% |
|
Latin America
|
0.34% |
| Brazil | 0.34% |
As of June 30, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 28.53% |
|---|---|
| United Kingdom | 12.71% |
|
Europe Developed
|
15.81% |
| Belgium | 4.87% |
| Denmark | 0.30% |
| Germany | 1.54% |
| Ireland | 3.91% |
| Netherlands | 0.28% |
| Sweden | 0.51% |
| Switzerland | 4.40% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 1.51% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
98.74% |
| Consumer Staples |
|
0.35% |
| Health Care |
|
98.40% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.76% |
| Non Classified Equity |
|
0.76% |
As of June 30, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |